TW201841944A - 4-1bbl變異體及包含其之融合蛋白 - Google Patents
4-1bbl變異體及包含其之融合蛋白 Download PDFInfo
- Publication number
- TW201841944A TW201841944A TW107113853A TW107113853A TW201841944A TW 201841944 A TW201841944 A TW 201841944A TW 107113853 A TW107113853 A TW 107113853A TW 107113853 A TW107113853 A TW 107113853A TW 201841944 A TW201841944 A TW 201841944A
- Authority
- TW
- Taiwan
- Prior art keywords
- 1bbl
- fragment
- 1bbl variant
- fusion protein
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
??10-2017-0052411 | 2017-04-24 | ||
KR20170052411 | 2017-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201841944A true TW201841944A (zh) | 2018-12-01 |
Family
ID=63919854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107113853A TW201841944A (zh) | 2017-04-24 | 2018-04-24 | 4-1bbl變異體及包含其之融合蛋白 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR20180119135A (ko) |
TW (1) | TW201841944A (ko) |
WO (1) | WO2018199595A1 (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019036855A1 (en) | 2017-08-21 | 2019-02-28 | Adagene Inc. | ANTI-CD137 MOLECULES AND THEIR USE |
WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
AU2020273903B2 (en) * | 2019-05-14 | 2024-05-09 | Progen Co Ltd | Novel modified immunoglobulin Fc-fusion protein and use thereof |
CA3139968A1 (en) * | 2019-06-05 | 2020-12-10 | Peter Peizhi Luo | Anti-cd137l antibodies and methods of using same |
EP3998282A4 (en) * | 2019-07-08 | 2023-08-09 | Progen Co., Ltd. | NEW FUSION PROTEIN AND ITS USE |
US20230043257A1 (en) * | 2020-01-21 | 2023-02-09 | Jinyu Zhang | Pharmaceutical composition and use thereof |
KR102559355B1 (ko) * | 2020-01-31 | 2023-07-25 | 주식회사 제넥신 | 항-taa 항체, 항-pd-l1 항체 및 il-2를 포함하는 융합단백질 및 이의 용도 |
WO2024088404A1 (en) * | 2022-10-28 | 2024-05-02 | Fbd Biologics Limited | Engineered 4-1bbl variants and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138500B1 (en) * | 1993-05-07 | 2006-11-21 | Immunex Corporation | Antibodies to human 4-1BB |
KR101156085B1 (ko) * | 2010-01-29 | 2012-06-20 | 국립암센터 | 4-1bb리간드(4-1bbl)오중합체 및 이의 용도 |
US11111284B2 (en) * | 2014-08-21 | 2021-09-07 | The General Hospital Corporation | Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing |
CN114751989A (zh) * | 2015-03-31 | 2022-07-15 | 豪夫迈·罗氏有限公司 | 包含三聚体tnf家族配体的抗原结合分子 |
-
2018
- 2018-04-23 KR KR1020180046882A patent/KR20180119135A/ko not_active Application Discontinuation
- 2018-04-24 TW TW107113853A patent/TW201841944A/zh unknown
- 2018-04-24 WO PCT/KR2018/004745 patent/WO2018199595A1/ko active Application Filing
Also Published As
Publication number | Publication date |
---|---|
KR20180119135A (ko) | 2018-11-01 |
WO2018199595A1 (ko) | 2018-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201841944A (zh) | 4-1bbl變異體及包含其之融合蛋白 | |
US11318201B2 (en) | Multimeric IL-15-based molecules | |
US20230390338A1 (en) | Antigen binding receptors | |
JP7191030B2 (ja) | Il-12及びil-18へのil-15系融合 | |
JP7282383B2 (ja) | タンパク質性ヘテロ二量体及びその用途 | |
CN111655716B (zh) | 基于il-15的与il-7和il-21的融合体 | |
KR102609197B1 (ko) | 인터류킨 15 단백질 복합체 및 그의 용도 | |
EP3606947B1 (en) | Immunoconjugates of il-2 with an anti-pd-1 and tim-3 bispecific antibody | |
US20220002401A1 (en) | Chimeric antigen receptor and its use | |
JP2022062001A (ja) | 抗pd-1抗体と突然変異il-2とまたはil-15とのイムノコンジュゲート | |
EP1606318B1 (en) | Improved fc fusion proteins | |
JP2002521053A (ja) | ヘテロミニ体 | |
KR20180057720A (ko) | 다가 Fv 항체 | |
TW201326214A (zh) | Bcma及cd3結合分子 | |
JP2008094853A (ja) | インターロイキン21受容体活性を調節する方法および組成物 | |
AU2020224160A1 (en) | Artificial immunosurveillance chimeric antigen receptor (AI-CAR) and cells expressing the same | |
JP2022538139A (ja) | 変異体インターロイキン-2及び抗cd8抗体を含む免疫複合体 | |
US20220133792A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
US20230322950A1 (en) | Antigen binding receptors | |
CN114450296A (zh) | Il2激动剂 | |
JP4635255B2 (ja) | 抗体医薬 | |
CN113795272A (zh) | 涉及car工程化的t细胞和细胞因子的治疗 | |
WO2021115333A1 (zh) | 一种融合蛋白及表达此蛋白的工程化免疫细胞及其应用 | |
WO2023094413A1 (en) | Improved antigen binding receptors | |
WO2023180511A1 (en) | Improved chimeric receptors |